AMAG PHARMACEUTICALS INC's ticker is AMAG and the CUSIP is 00163U106. A total of 177 filers reported holding AMAG PHARMACEUTICALS INC in Q2 2017. The put-call ratio across all filers is 2.26 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2020 | $0 | -100.0% | 78 | -7.1% | 0.00% | – |
Q4 2019 | $1,000 | 0.0% | 84 | 0.0% | 0.00% | – |
Q3 2019 | $1,000 | 0.0% | 84 | 0.0% | 0.00% | – |
Q2 2019 | $1,000 | 0.0% | 84 | +1.2% | 0.00% | – |
Q1 2019 | $1,000 | 0.0% | 83 | -12.6% | 0.00% | – |
Q4 2018 | $1,000 | 0.0% | 95 | +41.8% | 0.00% | – |
Q3 2018 | $1,000 | 0.0% | 67 | 0.0% | 0.00% | – |
Q2 2018 | $1,000 | -75.0% | 67 | -66.8% | 0.00% | -100.0% |
Q1 2018 | $4,000 | +100.0% | 202 | +23.9% | 0.00% | – |
Q4 2017 | $2,000 | -33.3% | 163 | 0.0% | 0.00% | -100.0% |
Q3 2017 | $3,000 | 0.0% | 163 | 0.0% | 0.00% | 0.0% |
Q2 2017 | $3,000 | -25.0% | 163 | 0.0% | 0.00% | 0.0% |
Q1 2017 | $4,000 | -33.3% | 163 | -11.4% | 0.00% | 0.0% |
Q4 2016 | $6,000 | +20.0% | 184 | 0.0% | 0.00% | 0.0% |
Q3 2016 | $5,000 | +150.0% | 184 | +95.7% | 0.00% | – |
Q2 2016 | $2,000 | 0.0% | 94 | +11.9% | 0.00% | – |
Q1 2016 | $2,000 | 0.0% | 84 | +42.4% | 0.00% | – |
Q4 2015 | $2,000 | – | 59 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Palo Alto Investors LP | 3,344,620 | $116,393,000 | 6.64% |
Consonance Capital Management LP | 1,026,902 | $35,736,000 | 3.92% |
FALCON POINT CAPITAL, LLC | 801,944 | $27,908,000 | 3.74% |
Credit Capital Investments LLC | 72,813 | $2,534,000 | 3.24% |
Crosspoint Capital Strategies, LLC | 99,274 | $3,455,000 | 3.07% |
Camber Capital Management LP | 611,390 | $21,276,000 | 1.11% |
IRONWOOD INVESTMENT MANAGEMENT LLC | 40,901 | $1,423,000 | 1.04% |
BOGLE INVESTMENT MANAGEMENT L P /DE/ | 344,103 | $11,974,000 | 0.83% |
STELLIAM INVESTMENT MANAGEMENT, LP | 572,500 | $19,923,000 | 0.66% |
AlphaOne Investment Services, LLC | 66,105 | $2,301,000 | 0.64% |